These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2326400)

  • 21. Urinary phenylacetic acid in panic disorder with and without depression.
    Sabelli HC; Javaid JI; Fawcett J; Kravitz HM; Wynn P
    Acta Psychiatr Scand; 1990 Jul; 82(1):14-6. PubMed ID: 2399814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Psychopharmacology (Berl); 1987; 92(1):14-24. PubMed ID: 3110824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin response to the cold pressor test in patients with panic attacks.
    Grunhaus L; Gloger S; Birmacher B; Palmer C; Ben-David M
    Psychiatry Res; 1983 Mar; 8(3):171-7. PubMed ID: 6574536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperventilation and panic attacks.
    Kenardy J; Oei TP; Evans L
    Aust N Z J Psychiatry; 1990 Jun; 24(2):261-7. PubMed ID: 2118758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Situational panic attacks. Behavioral, physiologic, and biochemical characterization.
    Woods SW; Charney DS; McPherson CA; Gradman AH; Heninger GR
    Arch Gen Psychiatry; 1987 Apr; 44(4):365-75. PubMed ID: 2882735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet serotonin levels in panic disorder.
    Balon R; Pohl R; Yeragani V; Rainey J; Oxenkrug GF
    Acta Psychiatr Scand; 1987 Mar; 75(3):315-7. PubMed ID: 3591415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The drug-free period: a methodological issue.
    Asnis GM; Harkavy Friedman JM; Iqbal N; Bajwa WK; Kalus O; Rubinson E; Grosz D; van Praag HM; Cooper TB
    Biol Psychiatry; 1990 Mar; 27(6):657-60. PubMed ID: 2182134
    [No Abstract]   [Full Text] [Related]  

  • 28. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine.
    Judd FK; Apostolopoulos M; Burrows GD; Norman TR
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):329-37. PubMed ID: 8208982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dexamethasone suppression test in panic disorder.
    Judd FK; Norman TR; Burrows GD; McIntyre IM
    Pharmacopsychiatry; 1987 May; 20(3):99-101. PubMed ID: 3602097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin and sodium lactate-induced panic.
    Hollander E; Liebowitz MR; Cohen B; Gorman JM; Fyer AJ; Papp LA; Klein DF
    Psychiatry Res; 1989 May; 28(2):181-91. PubMed ID: 2748770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of low pulmonary CO2 on panic anxiety.
    Griez E; Zandbergen J; Lousberg H; van den Hout M
    Compr Psychiatry; 1988; 29(5):490-7. PubMed ID: 3141112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.
    Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM
    Psychiatry Res; 1991 Apr; 37(1):25-34. PubMed ID: 1650487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet imipramine binding in patients with panic disorder and major familial depression.
    Pecknold JC; Chang H; Fleury D; Koszychi D; Quirion R; Nair NP; Suranyi-Cadotte BE
    J Psychiatr Res; 1987; 21(3):319-26. PubMed ID: 3681766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panic attacks and the dexamethasone suppression test.
    Sheehan DV; Claycomb JB; Surman OS; Baer L; Coleman J; Gelles L
    Am J Psychiatry; 1983 Aug; 140(8):1063-4. PubMed ID: 6869593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbidity of panic disorder and major depressive disorder: effects on platelet alpha 2 adrenergic receptors.
    Grunhaus LJ; Cameron O; Pande AC; Haskett RF; Hollingsworth PJ; Smith CB
    Acta Psychiatr Scand; 1990 Mar; 81(3):216-9. PubMed ID: 2160772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Panic attack frequency and vulnerability to anxiogenic challenge studies.
    Targum SD
    Psychiatry Res; 1991 Jan; 36(1):75-83. PubMed ID: 2017525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered plasma dexamethasone and cortisol suppressibility in patients with panic disorders.
    Carson SW; Halbreich U; Yeh CM; Goldstein S
    Biol Psychiatry; 1988 May; 24(1):56-62. PubMed ID: 3370278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dexamethasone suppression test in inpatients with panic disorder or agoraphobia with panic attacks.
    Grunhaus L; Tiongco D; Haskett RF; Greden JF
    Biol Psychiatry; 1987 Apr; 22(4):517-21. PubMed ID: 3567265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.